• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

Dow Chemical Asks Trump Officials to Ignore Damning Pesticide Reports

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
April 20, 2017, 3:33 PM ET

Updated 5:40pm, 4/20: A statement from Dow Chemical has been added to this story.

Dow Chemical asked three high-ranking Trump administration officials to ignore government scientists’ own studies about the environmental risks posed by a major class of pesticides, according to the Associated Press.

The AP got its hands on letters that Dow sent to the Secretaries of Commerce and the Interior (Wilbur Ross and Ryan Zinke, respectively) and Environmental Protection Agency (EPA) administrator Scott Pruitt—a noted opponent of environmental regulations and climate change skeptic who’s already moved to scrap Obama-era restrictions on certain pesticides. Last month, Pruitt reversed his own agency’s proposal to ban chlorpyrifos, which has been linked to brain damage in children exposed to the pest-killer.

It was against this backdrop that Dow, along with two other pesticide manufacturers, asked Trump officials to disregard government research that indicates a group of commonly used agriculture pesticides are harmful to 1,800 endangered and critically threatened animal species. In response, Dow is claiming these findings are flawed and should be “set aside” by the White House when considering proposed environmental protection rules. (When a team of the company’s own scientists examined the matter, Dow said, they came back with different results.)

Meanwhile Brett Hartl, a government scientist, is worried about how these chemicals could impact human health. “Endangered species are the canary in the coal mine,” he told the AP, since many of them reside in lakes and streams that serve as sources for human drinking water.

In response to the story, Dow said:

“No pest control product has been more thoroughly evaluated, with more than 4,000 studies and reports examining chlorpyrifos in terms of health, safety and the environment. Chlorpyrifos is authorized for use not only in the U.S., but nearly 100 nations, including Australia, Brazil, Canada, Italy and Japan. Dow AgroSciences remains confident that authorized uses of chlorpyrifos products offer wide margins of protection for human health and safety…

…Dow actively participates in policymaking and political processes, including political contributions to candidates, parties and causes, in compliance with all applicable federal and state laws. Dow maintains and is committed to the highest standard of ethical conduct in all such activity.”

“We have had no meetings with Dow on this topic and we are reviewing petitions as they come in, giving careful consideration to sound science and good policymaking,” J.P. Freire, the EPA’s associate administrator for public affairs, told the outlet. “The administrator is committed to listening to stakeholders affected by EPA’s regulations, while also reviewing past decisions.”

Dow is currently in the midst of a $62 billion attempted merger with DuPont; the companies received a regulatory thumbs-up from the European Union after agreeing to make big divestitures and split into three separate publicly traded companies after the corporate marriage.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

HealthAffordable Care Act (ACA)
A Wisconsin couple was paying $2 a month for an ACA health plan. But as subsidies expire, it’s soaring to $1,600, forcing them to downgrade
By Ali Swenson and The Associated PressDecember 13, 2025
17 hours ago
Julian Braithwaite is the Director General of the International Alliance for Responsible Drinking
CommentaryProductivity
Gen Z is drinking 20% less than Millennials. Productivity is rising. Coincidence? Not quite
By Julian BraithwaiteDecember 13, 2025
18 hours ago
Nicholas Thompson
C-SuiteBook Excerpt
I took over one of the most prestigious media firms while training for an ultramarathon. Here’s what I learned becoming CEO of The Atlantic
By Nicholas ThompsonDecember 13, 2025
20 hours ago
Healthmeal delivery
Factor Meals Review 2025: Tester Approved
By Christina SnyderDecember 12, 2025
1 day ago
Donald Trump
HealthHealth Insurance
‘Tragedy in the making’: Top healthcare exec on why insurance will spike to subsidize a tax cut to millionaires and billionaires
By Nick LichtenbergDecember 12, 2025
2 days ago
HelloFresh meal delivery service.
Healthmeal delivery
HelloFresh Review : We Tasted Everything so You Don’t Have To
By Christina SnyderDecember 12, 2025
2 days ago

Most Popular

placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
2 days ago
placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
2 days ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
2 days ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple CEO Tim Cook out-earns the average American’s salary in just 7 hours—to put that into context, he could buy a new $439,000 home in just 2 days
By Emma BurleighDecember 12, 2025
2 days ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
2 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.